Indian pharmaceutial company Bravo Group is set to begin building two pharmaceutical drug factories in the near future — one in Jüri and the other in Uganda — both of which will employ Estonian specialists.
Bravo Group first gained attention in Estonian media when it became a major shareholder in Estonia's Cancer Research Technology Development Centre (VTAK) last fall.
The business seeks to use Estonia a base for research and development work for the production of pharmaceutical drugs. The drugs will likewise be certified in Estonia.
The two factories to be built will begin producing generic drugs. Estonian specialists will be tasked at both locations with ensuring that, prior to production, the generic drugs have the same effects as the original.
Editor: Aili Vahtla